8-KLeadership ChangesExhibits & Filings

3M CO 8-K Report, Executive Changes (Aug 13, 2018)

Filed August 13, 2018For Securities:MMM

Summary

This 8-K filing from 3M Company (MMM) announced a key change in its Board of Directors. Effective August 12, 2018, the company elected Dambisa F. Moyo to its Board. Dr. Moyo brings significant leadership experience as the founder and CEO of Mildstorm, LLC. Her appointment increases the Board's size to 13 directors and fills a newly created vacancy, demonstrating an expansion of the company's governance oversight. Crucially for investors, Dr. Moyo has been deemed an independent director by the New York Stock Exchange and 3M's own guidelines, meeting stringent criteria including those for audit committee members. Furthermore, she has been appointed to both the Audit and Finance committees of the Board. Her qualifications are further underscored by the determination that she is "financially literate" and possesses "accounting or related financial management expertise," meeting the SEC's definition of an "audit committee financial expert." This addition enhances the financial oversight capabilities of 3M's Board.

Key Highlights

  • 1Appointment of Dambisa F. Moyo to the Board of Directors, effective August 12, 2018.
  • 2Dr. Moyo is the founder and CEO of Mildstorm, LLC.
  • 3Board size increased from 12 to 13 directors to accommodate the new appointment.
  • 4Dr. Moyo has been determined to be an independent director under NYSE and 3M's guidelines.
  • 5Appointment to the Audit and Finance committees of the Board of Directors.
  • 6Dr. Moyo is considered a "financially literate" individual with "accounting or related financial management expertise."
  • 7Designated as an "audit committee financial expert" per SEC regulations.

Frequently Asked Questions

Dambisa F. Moyo is the founder and CEO of Mildstorm, LLC. She has been elected to 3M's Board of Directors to enhance its governance and financial oversight capabilities, bringing her leadership and financial expertise to the company.

Her appointment to these committees is significant as it directly strengthens the Board's oversight of financial reporting, internal controls, and financial strategy. Her designation as an 'audit committee financial expert' further assures investors of robust financial scrutiny.

Yes, her status as an independent director is crucial. It ensures that the Board can make decisions objectively, without undue influence from management, thereby aligning with best corporate governance practices and investor expectations for independent oversight.

Dr. Moyo will participate in the standard compensation program for 3M's non-employee directors, as previously outlined in the company's 2018 Proxy Statement.